Johnson County Clin-Trials(JCCT)

Lenexa, Kansas 66219-1376

1 studies enrolling now · 14 studies all time

What they study most

Acute Gastroenteritis, Atropine Bioequivalence, Cystic Fibrosis (CF), Exocrine Pancreatic Insufficiency (EPI), Genital Herpes, Herpes Zoster, Influenza, Nipah Virus Infection, Norovirus Acute Gastroenteritis, Norovirus Infections, Pancreatic Diseases, Pancreatic Enzyme Abnormality

Studies at this site

• A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of Age — Stopped early
• A Trial of a Norovirus G1.1 and G2.4 Vaccine Administered Orally to Healthy Participants Aged ≥ 18 Years and ≤ 80 Years Old — Completed
• Assess Safety and Immunogenicity of A/H5 Inactivated Monovalent Influenza Vaccines at Different Antigen Dose Levels Adjuvanted With AS03 or MF59 — Completed
• Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49 — Running, not enrolling
• A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis — Running, not enrolling
• A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes — Completed
• A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency. — Starting soon
• Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age — Running, not enrolling
• Sublingual Atropine Bioequivalence by Route of Administration (SABER) — Completed
• A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age — Completed
• Study of mRNA-1010 Seasonal Influenza Vaccine in Adults — Completed
• A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older — Completed
• A Phase 1 Study to Evaluate Safety & Immunogenicity of RVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects — Completed
• Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant MVA BN® RSV Vaccine — Completed